These small cap ASX shares surged more than 100% in February

From a new BNPL agreement to cancer detection, these 3 small cap ASX shares made game changing announcements in February.
The post These small cap ASX shares surged more than 100% in February appeared first on The Motley Fool Australia. –

man standing with arms crossed in front of giant shadow of body builder representing asx small cap stocks

The small-cap space is always filled with explosive ASX shares looking to emerge as the next big thing. Here are the small-cap ASX shares that made headlines in February. 

1. Province Resources Ltd (ASX: PRL) 

The Province Resources share price surged an eye-watering 460% on 17 February. It’s a Cinderella story for a small-cap ASX share to announce the right kind of acquisition at a time where there is significant investor appetite for green projects. 

The company announced its intention to acquire Ozexco Pty Ltd. Ozexco holds 7 exploration licenses in the Gascoyne region in Western Australia, a region that is also one of the hottest and windiest areas with significant solar and wind potential. 

The initial exploration and evaluation will be focused on the salt, potash, mineral sands and renewable hydrogen potential over the tenement area. This would make Province the first listed green hydrogen player on the ASX. 

After surging from 2.6 cents to 14.5 cents in just one day, its shares have cooled down to close at 9 cents today. 

2. BARD1 Life Sciences Ltd (ASX: BD1) 

The BARD1 share price found itself running as high as 650% in just six days after the company announced that it’s SubB2M technology could detect all stages of ovarian cancer and disease recurrence.

BARD1 CSO Dr Peter French said:

Whilst this data is preliminary, these excellent results reported by the researchers at Griffith University support the commercial potential of SubB2M for both breast and ovarian cancer monitoring and detection.

This is ground-breaking research since Neu5Gc is a highly specific marker for cancer and BARD1 is using SubB2M alone or in combination with other tissue-specific cancer markers to develop highly-specific tests for breast, ovarian, prostate and pancreatic cancers.

BARD1 plans to develop and commercialise SUbB2M-based blood tests initially for monitoring patients already diagnosed with breast cancer for treatment response and recurrence.

The company expects to report the outcomes of its SubB2M test validation studies by the end of Q3 CY21. 

3. Ioupay Ltd (ASX: IOU) 

Ioupay was arguably the dark horse of the buy now, pay later (BNPL) sector. While BNPL shares across the board were surging at the beginning of February, Ioupay was quietly waiting to announce a game-changer. 

On 9 February, the company announced that it had entered into a Merchant Referral Agreement with EasyStore Commerce to enable EasyStore’s merchants and end-user customers to utilise Ioupay’s BNPL payment services. 

EasyStore services more than 7,000 merchants across the South East Asian (SEA) markets, including Malaysia, Singapore, Indonesia, Philippines, Thailand, Hong Kong and Taiwan. Some 5,000 of these are in Malaysia, with a growing portfolio of merchants in the US. 

In 2020, EasyStore merchants processed a total transaction volume of approximately $435 million. The two companies have started integrating systems with BNPL payment processing capabilities to begin onboarding merchants and approved customers by early March this year. 

It was almost as if the words ‘buy now, pay later’ were enough to send its shares into a buying frenzy. By 18 February, the ioupay share price had ripped 280% higher to a high of 85 cents before management decided it was time to announce a $50 million placement to support its growth initiatives further. 

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post These small cap ASX shares surged more than 100% in February appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!